Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network

Clinical trial NCT07445347 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07445347
Sponsor: Poitiers University Hospital
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Hereditary Hemorrhagic Telangiectasia (HHT)Pulmonary Hypertension Bevacizumab

Start date: 2025-10-15
Primary completion: 2026-06-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.